title: Tumor-associated immune parameters for personalized patient care.
abstract: The implementation of a robust technology adapted to clinical practice for the evaluation of the tumor-immune infiltrate is required to exploit its prognostic and theranostic value (Robins et al., this issue).
authors.affiliation: Laboratory of Immunology, Immunomonitoring Platform, Georges Pompidou European Hospital, AP-HP, Paris Descartes University, Laboratory of Integrative Cancer Immunology, INSERM U872, Cordeliers Research Center, Paris, France.
authors.forename: Franck
authors.initials: F
authors.lastname: Pagès
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D005260:Female; D023281:Genomics; D006801:Humans; D007111:Immunity, Cellular / Q000235:genetics*; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D010051:Ovarian Neoplasms / Q000235:genetics*; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor